AbbVie Inc. (ABBV) Financials
Annual revenue, profitability and per-share results for AbbVie Inc., as reported in SEC filings.
Revenue · FY2025
$61.16B
▲ 8.6%YoY
Net income · FY2025
$4.23B
▼ 1.2%YoY
Diluted EPS · FY2025
$2.36
▼ 1.3%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS |
|---|---|---|---|---|
| FY2025 | $61.16B | $4.23B | — | $2.36 |
| FY2024 | $56.33B | $4.29B | — | $2.39 |
| FY2023 | $54.32B | $4.87B | — | $2.72 |
| FY2022 | $58.05B | $11.85B | — | $6.63 |
Figures as reported in AbbVie Inc.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Financials for companies related to ABBV
Never miss a ABBV filing.
Get an email when ABBV files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.